Why the study?
Does anti-Ro (SS-A) binding differ between a patient with congenital complete heart block and a normal HLA-identical twin?
Does anti-Ro (SS-A) binding differ between a patient with congenital complete heart block and a normal HLA-identical twin?
The finding of 13-fold lower anti-Ro (SS-A) binding in a patient with congenital complete heart block compared to his normal twin supports the hypothesis that anti-Ro (SS-A) may be directly involved in its pathogenesis.
Answers are grounded in this paper and cite their sources.
Supports hypothesis of anti-Ro involvement in congenital heart block; hypothesis-generating from single case report.
Congenital complete heart block is closely associated with the presence of anti-Ro (SS-A) autoantibodies. Quantitative solid-phase assays for Ro (SS-A) autoantigen and autoantibody have established the presence of Ro (SS-A) in cardiac tissues and have been used to evaluate an informative pedigree. The propositus we describe here had complete congenital heart block and showed anti-Ro (SS-A) binding of 13-fold less than his normal HLA-identical twin sister. Both had identical titers of antinuclear antibody. These data support the hypothesis that anti-Ro (SS-A) may be directly involved in the pathogenesis of congenital complete heart block.
No takes yet. Share an insight, caveat, or question.
Harley et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: